Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy : A pooled analysis of 6 prospective trials

✍ Scribed by Todd M. Bauer; Bassel F. El-Rayes; Xiaobai Li; Nazik Hammad; Philip A. Philip; Anthony F. Shields; Mark M. Zalupski; Tanios Bekaii-Saab

• Book ID: 112067281
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 327 KB
• Volume: 119
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.27734